U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"The production of too many useful things results in too many useless people."

Karl Marx

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Assignee: Arris Pharmaceutical Corporation


Location: SouthSanFrancisco, CA
No. of patents: 10

NumberTitleIssue Date
6485964TRANSGENIC MAMMALS LACKING EXPRESSION OF ERYTHROPOIETIN OR OF ERYTHROPOIETIN RECEPTOR, TRANSGENIC MAMMALS EXPRESSING CHIMERIC ERYTHROPOIETIN RECEPTORS, CONSTRUCTS FOR PRODUCING THE TRANSGENIC MAMMALS AND USES THEREFOR
Transgenic nonhuman mammals, such as transgenic mice, which lack erythropoietin expression, in which the erythropoietin receptor is deleted, which carry a heterologous erythropoietin receptor (e.g., a chimeric receptor); constructs useful for producing su...
11/26/2002
5776718Reversible protease inhibitors
The invention relates to novel reversible protease inhibitors. The inhibitors are specific to cysteine proteases....
07/07/1998
5703792Three dimensional measurement of molecular diversity
A method and system for selecting molecules or molecular parts for screening. A base set of molecules on which chemical tests are to be performed is defined, and once defined, the base set may be extended by selecting molecules which are determined to max...
12/30/1997
5693515Metal complexed serine protease inhibitors
Serine protease inhibitors are provided comprising compounds having a P site binding moiety and a divalent cation(s) chelating moiety which are pre-prepared as divalent cation(s) complexes or combined with the serine protease in the presence of divalent c...
12/02/1997
5656660Compositions and methods for treating mast-cell mediated conditions
The present invention describes compounds, methods and compositions effective to treat mast cell mediated inflammatory conditions, such as conjunctivitis, asthma and allergic rhinitis. The compounds of the invention comprise novel mono- and di-aminomethyl...
08/12/1997
5585275Pilot apparatus for peptide synthesis and screening
Method and apparatus for simple and rapid preparation of reusable, addressable surface-immobilized arrays of biomolecules (libraries) used for screening for interaction with any biologically significant target. A special plate having on or in its surface ...
12/17/1996
5576220Thin film HPMP matrix systems and methods for constructing and displaying ligands
The invention relates to methods and systems of unhindered construction and display of tethered organic ligand molecules, and more particularly to preparation and use of thin film, substantially non-crosslinked hydrophilic polar multi-functionalized polym...
11/19/1996
5567602Recombinant production of chymase
The instant invention is directed to recombinant production of functionally active chymase. "Functionally active" as used herein refers to the ability to exhibit one or more functional activities of a full-length wild-type chymase protein. In a preferred ...
10/22/1996
5526281Machine-learning approach to modeling biological activity for molecular design and to modeling other characteristics
Explicit representation of molecular shape of molecules is combined with neural network learning methods to provide models with high predictive ability that generalize to different chemical classes where structurally diverse molecules exhibiting similar s...
06/11/1996
5525623Compositions and methods for the treatment of immunomediated inflammatory disorders
Compositions and methods for the prevention and treatment of immunomediated inflammatory disorders, especially for those disorders associated with the respiratory tract, are provided. More particularly, a tryptase inhibitor, typically a hydroxyaroyl or hy...
06/11/1996
 
Sign InRegister
Username  
Password   
forgot password?